肯尼亚三级医院化疗相关发热性中性粒细胞减少症菌血症的结果和微生物学模式。

IF 1.7 Q4 INFECTIOUS DISEASES
IJID regions Pub Date : 2025-07-18 eCollection Date: 2025-09-01 DOI:10.1016/j.ijregi.2025.100708
Abhijit Ghose, Jasmit Shah, Anne Mwirigi, Charles Makasa, Felix Riunga
{"title":"肯尼亚三级医院化疗相关发热性中性粒细胞减少症菌血症的结果和微生物学模式。","authors":"Abhijit Ghose, Jasmit Shah, Anne Mwirigi, Charles Makasa, Felix Riunga","doi":"10.1016/j.ijregi.2025.100708","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Febrile neutropenia (FN) is a major cause of mortality and morbidity in patients with malignancy post-chmotherapy. Current guidelines for managing FN recommend starting empiric antibiotic therapy (EAT) promptly. The choice of antibiotic is based on the patient's condition, local data on common microorganisms isolated, and their resistance patterns. Of note, there is a growing trend of isolating multi-drug-resistant gram-negative bacteria in these patients. In sub-Saharan Africa, there are insufficient data on the mortality rates of FN. There is also a lack of local epidemiologic data on the frequently isolated microorganisms and their antibiotic resistance patterns. This makes it challenging to determine the appropriate EAT for patients with FN. This study aimed to determine the mortality rates of FN in patients with cancer and characterize the isolated microorganisms and their resistance patterns.</p><p><strong>Methods: </strong>This was a retrospective descriptive study of adult patients with cancer hospitalized with FN post-chemotherapy between January 2017 and July 2022 at Aga Khan University Hospital, Kenya. Continuous variables are expressed as medians with inter-quartile ranges whereas categorical variables are expressed as frequencies and percentages.</p><p><strong>Results: </strong>A total of 90 episodes of FN involving 50 unique patients were identified from medical records. The median age was 42.8 years (inter-quartile range: 31.3-65.0). Male patients accounted for 67.0% (n = 60). Hematologic malignancies accounted for 90.0% (n = 81). The mortality rate was 26.0% (n = 13), with 84.6% (n = 11) having a hematologic malignancy. Of the 90 episodes, 27.8% (25) had positive blood cultures; 68.0% (17) were gram-negative, 24.0% (six) were gram-positive, and 8.0% (two) were candida species. <i>Klebsiella pneumoniae</i> was the most common bacteria isolated. Among gram-negative bacteremia, 23.5% (four) were third-generation cephalosporin-resistant and 11.7% (two) were carbapenem-resistant.</p><p><strong>Conclusions: </strong>The study found a higher mortality rate in patients with FN in East Africa than in North America. Gram-negative bacteria were the most commonly isolated pathogens in blood cultures, with a growing concern over the increasing prevalence of multi-drug-resistant strains. Further multi-centered studies involving larger sample sizes are required to help develop regional guidelines for the choice of EAT in the management of FN.</p>","PeriodicalId":73335,"journal":{"name":"IJID regions","volume":"16 ","pages":"100708"},"PeriodicalIF":1.7000,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12351340/pdf/","citationCount":"0","resultStr":"{\"title\":\"Outcomes and microbiological patterns of bacteremia in chemotherapy-related febrile neutropenia at a tertiary facility in Kenya.\",\"authors\":\"Abhijit Ghose, Jasmit Shah, Anne Mwirigi, Charles Makasa, Felix Riunga\",\"doi\":\"10.1016/j.ijregi.2025.100708\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Febrile neutropenia (FN) is a major cause of mortality and morbidity in patients with malignancy post-chmotherapy. Current guidelines for managing FN recommend starting empiric antibiotic therapy (EAT) promptly. The choice of antibiotic is based on the patient's condition, local data on common microorganisms isolated, and their resistance patterns. Of note, there is a growing trend of isolating multi-drug-resistant gram-negative bacteria in these patients. In sub-Saharan Africa, there are insufficient data on the mortality rates of FN. There is also a lack of local epidemiologic data on the frequently isolated microorganisms and their antibiotic resistance patterns. This makes it challenging to determine the appropriate EAT for patients with FN. This study aimed to determine the mortality rates of FN in patients with cancer and characterize the isolated microorganisms and their resistance patterns.</p><p><strong>Methods: </strong>This was a retrospective descriptive study of adult patients with cancer hospitalized with FN post-chemotherapy between January 2017 and July 2022 at Aga Khan University Hospital, Kenya. Continuous variables are expressed as medians with inter-quartile ranges whereas categorical variables are expressed as frequencies and percentages.</p><p><strong>Results: </strong>A total of 90 episodes of FN involving 50 unique patients were identified from medical records. The median age was 42.8 years (inter-quartile range: 31.3-65.0). Male patients accounted for 67.0% (n = 60). Hematologic malignancies accounted for 90.0% (n = 81). The mortality rate was 26.0% (n = 13), with 84.6% (n = 11) having a hematologic malignancy. Of the 90 episodes, 27.8% (25) had positive blood cultures; 68.0% (17) were gram-negative, 24.0% (six) were gram-positive, and 8.0% (two) were candida species. <i>Klebsiella pneumoniae</i> was the most common bacteria isolated. Among gram-negative bacteremia, 23.5% (four) were third-generation cephalosporin-resistant and 11.7% (two) were carbapenem-resistant.</p><p><strong>Conclusions: </strong>The study found a higher mortality rate in patients with FN in East Africa than in North America. Gram-negative bacteria were the most commonly isolated pathogens in blood cultures, with a growing concern over the increasing prevalence of multi-drug-resistant strains. Further multi-centered studies involving larger sample sizes are required to help develop regional guidelines for the choice of EAT in the management of FN.</p>\",\"PeriodicalId\":73335,\"journal\":{\"name\":\"IJID regions\",\"volume\":\"16 \",\"pages\":\"100708\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2025-07-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12351340/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"IJID regions\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ijregi.2025.100708\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/9/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"IJID regions","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.ijregi.2025.100708","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

摘要

发热性中性粒细胞减少症(FN)是化疗后恶性肿瘤患者死亡和发病的主要原因。目前FN管理指南建议立即开始经验性抗生素治疗(EAT)。抗生素的选择应根据患者的病情、分离出的常见微生物的当地数据及其耐药模式。值得注意的是,在这些患者中分离多重耐药革兰氏阴性菌的趋势越来越明显。在撒哈拉以南非洲,FN死亡率的数据不足。也缺乏关于经常分离的微生物及其抗生素耐药性模式的当地流行病学数据。这使得确定FN患者合适的饮食具有挑战性。本研究旨在确定FN在癌症患者中的死亡率,并表征分离的微生物及其耐药模式。方法:这是一项回顾性描述性研究,研究对象是2017年1月至2022年7月在肯尼亚阿迦汗大学医院因化疗后FN住院的成年癌症患者。连续变量表示为四分位数范围内的中位数,而分类变量表示为频率和百分比。结果:从医疗记录中共发现90例FN发作,涉及50例独特患者。中位年龄为42.8岁(四分位数间距:31.3-65.0岁)。男性患者占67.0% (n = 60)。血液恶性肿瘤占90.0% (n = 81)。死亡率为26.0% (n = 13),其中84.6% (n = 11)患有血液恶性肿瘤。90例患者中,27.8%(25例)血培养阳性;革兰氏阴性17例(68.0%),革兰氏阳性6例(24.0%),念珠菌2例(8.0%)。肺炎克雷伯菌是最常见的细菌。革兰氏阴性菌血症中,23.5%(4例)对第三代头孢菌素耐药,11.7%(2例)对碳青霉烯耐药。结论:研究发现,东非FN患者的死亡率高于北美。革兰氏阴性菌是血液培养中最常见的分离病原体,人们越来越关注多重耐药菌株的日益流行。需要进一步开展涉及更大样本量的多中心研究,以帮助制定在FN管理中选择EAT的区域指南。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Outcomes and microbiological patterns of bacteremia in chemotherapy-related febrile neutropenia at a tertiary facility in Kenya.

Introduction: Febrile neutropenia (FN) is a major cause of mortality and morbidity in patients with malignancy post-chmotherapy. Current guidelines for managing FN recommend starting empiric antibiotic therapy (EAT) promptly. The choice of antibiotic is based on the patient's condition, local data on common microorganisms isolated, and their resistance patterns. Of note, there is a growing trend of isolating multi-drug-resistant gram-negative bacteria in these patients. In sub-Saharan Africa, there are insufficient data on the mortality rates of FN. There is also a lack of local epidemiologic data on the frequently isolated microorganisms and their antibiotic resistance patterns. This makes it challenging to determine the appropriate EAT for patients with FN. This study aimed to determine the mortality rates of FN in patients with cancer and characterize the isolated microorganisms and their resistance patterns.

Methods: This was a retrospective descriptive study of adult patients with cancer hospitalized with FN post-chemotherapy between January 2017 and July 2022 at Aga Khan University Hospital, Kenya. Continuous variables are expressed as medians with inter-quartile ranges whereas categorical variables are expressed as frequencies and percentages.

Results: A total of 90 episodes of FN involving 50 unique patients were identified from medical records. The median age was 42.8 years (inter-quartile range: 31.3-65.0). Male patients accounted for 67.0% (n = 60). Hematologic malignancies accounted for 90.0% (n = 81). The mortality rate was 26.0% (n = 13), with 84.6% (n = 11) having a hematologic malignancy. Of the 90 episodes, 27.8% (25) had positive blood cultures; 68.0% (17) were gram-negative, 24.0% (six) were gram-positive, and 8.0% (two) were candida species. Klebsiella pneumoniae was the most common bacteria isolated. Among gram-negative bacteremia, 23.5% (four) were third-generation cephalosporin-resistant and 11.7% (two) were carbapenem-resistant.

Conclusions: The study found a higher mortality rate in patients with FN in East Africa than in North America. Gram-negative bacteria were the most commonly isolated pathogens in blood cultures, with a growing concern over the increasing prevalence of multi-drug-resistant strains. Further multi-centered studies involving larger sample sizes are required to help develop regional guidelines for the choice of EAT in the management of FN.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
IJID regions
IJID regions Infectious Diseases
CiteScore
1.60
自引率
0.00%
发文量
0
审稿时长
64 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信